Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that can be used for vaccination purposes, to induce a specific T-cell response in vivo against melanoma-associated antigens. We have shown that the sequential use of early-acting hematopoietic growth factors, stem cell factor, I...
Главные авторы: | Mackensen, A, Herbst, B, Chen, J, Köhler, G, Noppen, C, Herr, W, Spagnoli, G, Cerundolo, V, Lindemann, A |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2000
|
Схожие документы
-
Induction of antigen-specific immune responses in melanoma patients after vaccination with peptide-pulsed dendritic cells.
по: Mackensen, A, и др.
Опубликовано: (1999) -
Dendritic Cell Lineage Potential in Human Early Hematopoietic Progenitors
по: Julie Helft, и др.
Опубликовано: (2017-07-01) -
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
по: Takesako Kazutoh, и др.
Опубликовано: (2005-01-01) -
Transient loading of CD34+ hematopoietic progenitor cells with polystyrene nanoparticles
по: Deville S, и др.
Опубликовано: (2017-01-01) -
Generation and function of progenitor T cells from StemRegenin-1–expanded CD34+ human hematopoietic progenitor cells
по: Jastaranpreet Singh, и др.
Опубликовано: (2019-10-01)